A post by @FirstSquawk on X.
MICROSOFT SAYS MAI TRANSCRIBE 2 HAS NOW LAUNCHED IN DRAGON COPILOT FOR MEDICAL USE CASES, AND THAT VOICE AI MAI REALTIME 1 OUTPERFORMS GPT REALTIME 2.1 ON PUBLIC BENCHMARKS AND MICROSOFT PRODUCT EVALUATIONS
@FirstSquawk on X
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
The announcement positions Microsoft's in-house MAI models as competitive alternatives to OpenAI's realtime voice stack in both clinical documentation and broader voice applications. Dragon Copilot, Microsoft's healthcare-focused documentation assistant, now runs the new transcription model for medical use cases. The claim that MAI Realtime 1 beats GPT Realtime 2.1 on Microsoft's own evaluations matters because it signals the company is benchmarking its proprietary models against the OpenAI systems it has long relied on. Next, watch for independent benchmark results and any pricing or availability details for MAI Realtime 1 across Microsoft products.
Muhabbit's AI wrote this summary of @FirstSquawk's post in its own words. It can get details wrong, so read the post on X.
Named in this story
Microsoft (MSFT), MAI Realtime 1, MAI Transcribe 2, Dragon Copilot, GPT Realtime 2.1
A linked name opens that asset's sentiment page.